7
Reducing Patient Anxiety Pre-cardiac Catheterization Through Education
- Thu, 7/31/08 - 3:57pm
- 0 Comments
- 5258 reads
Q & A with Author Jeremy Whitehead:New Book Profiles a Spouse’s Account of SCA
- Thu, 7/31/08 - 3:57pm
- 0 Comments
- 2777 reads
Tell us about what happened to Carolyn the day of her SCA.
My wife Carolyn and I had recently married and had moved from Australia to Boston, where at the time she was working for IBM. She had a business trip in Dallas shortly after we were married. During her trip, I received a phone call from her boss saying she ‘had had a bit of a turn’ and that they had sent her off to the hospital — he was understating things severely. What had happened is that while at her business conference, after just having introduced herself to everyone in the room and sitting down, she collapsed to the ground. Luckily, two male colleagues helped her immediately as well as a nurse attending the conference center.
Measuring the Effectiveness of Wearable Defibrillators and Implantable Devices: EP Lab Digest Speaks with Jeffrey Olgin, MD
- Thu, 7/31/08 - 3:57pm
- 0 Comments
- 2780 reads
Measuring the Effectiveness of Wearable Defibrillators and Implantable Devices: EP Lab Digest Speaks with Jeffrey Olgin, MD About the VEST/PREDICTS Study
Tell us about the new VEST/PREDICTS study. What are the main objectives of both parts of the study?
The Vest Prevention of Early Sudden Death Trial/Prediction of ICD Therapies Study (VEST/PREDICTS) is an NIH-funded, multi-center, randomized clinical trial and an observational study wrapped into one — it is one study that answers two questions by combining two studies in a single cohort. The study also receives funding from Medtronic, Zoll-Lifecor and GE.
Spotlight Interview: Adventist Hinsdale Hospital
- Thu, 7/31/08 - 3:57pm
- 0 Comments
- 4349 reads
Five Giants in Electrophysiology
- Thu, 7/31/08 - 3:57pm
- 0 Comments
- 3431 reads
“If I have seen farther, it is by standing on the shoulders of Giants.”
— Sir Isaac Newton
I have been involved with cardiac catheterization and electrophysiology for almost 30 years. I started out as a biomedical technician and then gravitated into the cath lab. My first day in the lab was in January of 1979. Over the following decades, I moved from the clinical environment to industry and back again...several times. My career path almost always revolved around cardiology, so I have built up a resume that looks like a patchwork quilt of experience; this has afforded me quite a perspective — meaning, I’ve heard a lot of stories.
Ablation of Ventricular Tachycardia in a Patient with Traumatic Ventricular Septal Defect
- Thu, 7/31/08 - 3:57pm
- 0 Comments
- 3135 reads
Abstract
Ventricular tachycardia (VT) was mapped and ablated in a 34-year-old man with a history of a traumatic ventricular septal defect. Nonfluoroscopic three-dimensional (3D) mapping was used to guide the VT ablation.
Case Report
Overview on the Certificate Course in Cardiac Electrophysiology for Allied Professionals
- Thu, 7/31/08 - 3:57pm
- 0 Comments
- 2718 reads
10-Minute Interview: Andrea Natale, MD
- Thu, 7/31/08 - 3:57pm
- 0 Comments
- 3008 reads
Tell us about the creation of the Texas Cardiac Arrhythmia Institute (TCAI) at St. David's Medical Center. What attracted you to move to St. David's?
It was a combination of factors — the most important one is because of the group of very talented physicians here that are already doing a remarkable volume of clinical cases, which for me is important — I wanted to support and continue some of the pioneering work that they are doing. It is also because TCAI has all the technology that I needed to continue on with my academics. In addition, the hospital has been very generous in terms of their resources in adopting a research institute, so for me these benefits were all the evidence that I needed to quickly step in and continue my research and clinical work here.
Tell us about your blog on St. David's website. Will this be something you will update regularly?
Cardiostim 2008 Meeting Highlights
- Thu, 7/31/08 - 3:57pm
- 0 Comments
- 2105 reads
The AtriCure Minimally Invasive Platform Highlighted by Prominent Cardiac Surgeons and Electrophysiologists at Cardiostim in Nice, France
Email Discussion Group: July 2008
- Thu, 7/31/08 - 3:57pm
- 0 Comments
- 2440 reads
New Question:
Protocol for Tilt Table Study
I recently encountered a superior manager who halted all tilt studies unless the physician was at the bedside. Prior to this we were performing these exams while the MD was in the lab, within close proximity, and not directly watching the patient. We are only tilting the patient on a table and if they do not respond to an 80-degree tilt in 15 minutes, we spray nitro under the tongue. The worst that has happened is they have gone asystole [during which time] we place them at zero degrees, give fluids, or at the worst-case scenario, give atropine. They immediately respond. Are there any rules which state that the physician must be directly at the patient’s bedside? Are the nurses not qualified to do this if the physician is not within arm’s length?
— name withheld by request
(To reply to this question, please type “Protocol for Tilt Table Study” in your subject line.)
